Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Greillier

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
European Geriatric Medicine|May 18, 2021
Use and impact of the G8 score in older patients with thoracic and lung cancersAnne-Laure Couderc, Stéphanie Gentile, Emilie Nouguerède, et al.
International Journal of Molecular Sciences|December 22, 2016
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung CancerPascale Tomasini, Cindy Serdjebi, Nataliya Khobta, et al.
Lung Cancer (Auckland, N.Z.)|August 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced <i>ALK</i>+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)Renaud Descourt, Florian Guisier, Maurice Pérol, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2020
Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery?Pascal-Alexandre Thomas, Anne-Laure Couderc, David Boulate, et al.
Clinical Interventions in Aging|September 28, 2020
Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge StudyAnne-Laure Couderc, Celia Boisseranc, Dominique Rey, et al.
Preventive Medicine Reports|June 6, 2018
Beliefs and behavior regarding e-cigarettes in a large cross-sectional surveySébastien Couraud, Alexis B Cortot, Xavier B Pivot, et al.
Lung Cancer (Amsterdam, Netherlands)|September 28, 2021
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study)Jean-Bernard Auliac, Isabelle Monnet, Acya Bizieux, et al.
Oncotarget|March 2, 2018
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)Romain Corre, Radj Gervais, Florian Guisier, et al.
Oncology|October 3, 2018
Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in FranceLaurence Bigay-Gamé, Suzanna Bota, Laurent Greillier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 13, 2025
Is adjuvant chemotherapy beneficial in NSCLC patients over 75? Insights from a retrospective analysisYohann Vincent, Faustine Enoch, Vanessa Pauly, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
European Geriatric Medicine|May 18, 2021
Use and impact of the G8 score in older patients with thoracic and lung cancersAnne-Laure Couderc, Stéphanie Gentile, Emilie Nouguerède, et al.
International Journal of Molecular Sciences|December 22, 2016
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung CancerPascale Tomasini, Cindy Serdjebi, Nataliya Khobta, et al.
Lung Cancer (Auckland, N.Z.)|August 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced <i>ALK</i>+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)Renaud Descourt, Florian Guisier, Maurice Pérol, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2020
Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery?Pascal-Alexandre Thomas, Anne-Laure Couderc, David Boulate, et al.
Clinical Interventions in Aging|September 28, 2020
Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge StudyAnne-Laure Couderc, Celia Boisseranc, Dominique Rey, et al.
Preventive Medicine Reports|June 6, 2018
Beliefs and behavior regarding e-cigarettes in a large cross-sectional surveySébastien Couraud, Alexis B Cortot, Xavier B Pivot, et al.
Lung Cancer (Amsterdam, Netherlands)|September 28, 2021
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study)Jean-Bernard Auliac, Isabelle Monnet, Acya Bizieux, et al.
Oncotarget|March 2, 2018
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)Romain Corre, Radj Gervais, Florian Guisier, et al.
Oncology|October 3, 2018
Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in FranceLaurence Bigay-Gamé, Suzanna Bota, Laurent Greillier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 13, 2025
Is adjuvant chemotherapy beneficial in NSCLC patients over 75? Insights from a retrospective analysisYohann Vincent, Faustine Enoch, Vanessa Pauly, et al.
Pageof 16